From Texas Health and Human Services Commission <[email protected]>
Subject HHSC Sets Clinical Prior Authorization Implementation Dates This Spring
Date March 24, 2023 1:03 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Texas Health and Human Services [ [link removed] ]

Blue Gradient


HHSC Sets Clinical Prior Authorization Implementation Dates This Spring

HHSC will implement the following clinical prior authorizations for clients enrolled in Medicaid fee-for-service in the weeks ahead:


* Calcitonin Gene-Related Peptide Receptor Antagonists [ [link removed] ] (April 4)
* Antimigraine Agents (Triptans) [ [link removed] ] (April 4)
* Inhaled Antibiotics [ [link removed] ] (May 2)
* Sodium-glucose linked transporter-2 (SGLT-2) Agents [ [link removed] ] (May 2)
* Hyperlipidemia Agents [ [link removed] ] (May 2)
* Juxtapid criteria

* Zelboraf [ [link removed] ] (May 2)

 









________________________________________________________________________

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website [ [link removed] ].

________________________________________________________________________

Stay Connected Visit us on Facebook [ [link removed] ] Visit us on YouTube [ [link removed] ] Visit us on Twitter [ [link removed] ] Visit us on Instagram [ [link removed] ] Visit us on Facebook [ [link removed] ]  (en español)  

Bookmark and Share [ [link removed] ]

Subscriber Services
Manage Preferences [ [link removed] ]  |  Unsubscribe [ [link removed] ]  |  Help [ [link removed] ]

________________________________________________________________________

This email was sent to using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202 GovDelivery logo [ [link removed] ]
Screenshot of the email generated on import

Message Analysis